Why the study?
Does medical treatment after 1990 (including beta-blockers and ACE inhibitors) improve survival in patients with dilated cardiomyopathy compared to treatment before 1989?
Does medical treatment after 1990 (including beta-blockers and ACE inhibitors) improve survival in patients with dilated cardiomyopathy compared to treatment before 1989?
Survival of patients with dilated cardiomyopathy significantly improved in the 1990s, likely driven by the increased use of beta-blockers and ACE inhibitors.
Answers are grounded in this paper and cite their sources.
Post-1990 survival gains in dilated cardiomyopathy may relate to beta-blockers and ACE inhibitors; leaves open causal inference from this observational cohort.
To analyze the recent change in the long-term survival of patients with dilated cardiomyopathy (DCM), the present study comprised consecutive 111 patients with ejection fraction <50% and left ventricular end-diastolic diameter >58 mm. who were admitted to hospital from January 1983 to December 1994. The patients were divided into 2 groups: group A who were diagnosed before 1989 and group B diagnosed after 1990. Basic characteristics at diagnosis, including age, NYHA functional class, left ventricular end-diastolic diameter and ejection fraction, were similar between these 2 groups. Calculated survival rate at 5 years was 90.0% in group B in contrast to 62.3% in group A. Event-free survival also improved in group B. In group B, beta-blockers and angiotensin converting enzyme inhibitors were more frequently used than in group A (p<0.0001) whereas digitalis and other positive inotropic agents were significantly less used. Left ventricular ejection fraction was significantly improved during the follow-up period in patients treated with beta-blockers compared with those not treated with beta-blockers. These data indicate a significant improvement in the survival of patients with dilated cardiomyopathy after 1990, which may be explained by the change of medical treatment, especially the use of beta-blockers.
No takes yet. Share an insight, caveat, or question.
Azuma et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: